New MS Treatment Ublituximab Shows Promise in Trial

THURSDAY, Aug. 25, 2022 -- An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.
The drug, called ublituximab, beat a standard oral medication for MS...